[HTML][HTML] Progress in understanding and treating idiopathic pulmonary fibrosis: Recent insights and emerging therapies
H Guo, J Sun, S Zhang, Y Nie, S Zhou… - Frontiers in …, 2023 - frontiersin.org
Idiopathic pulmonary fibrosis (IPF) is a long-lasting, continuously advancing, and irrevocable
interstitial lung disorder with an obscure origin and inadequately comprehended …
interstitial lung disorder with an obscure origin and inadequately comprehended …
[HTML][HTML] Role of MicroRNAs in Signaling Pathways Associated with the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Focus on Epithelial-Mesenchymal Transition
AR Cadena-Suárez… - International Journal of …, 2022 - mdpi.com
Idiopathic pulmonary fibrosis (IPF) is a chronic and progressive disease with high mortality
and unclear etiology. Previous evidence supports that the origin of this disease is associated …
and unclear etiology. Previous evidence supports that the origin of this disease is associated …
Diagnostic and prognostic value of secreted phosphoprotein 1 for idiopathic pulmonary fibrosis: a systematic review and meta-analysis
Y Liao, R Wang, F Wen - Biomarkers, 2023 - Taylor & Francis
Background There is an increasing number of studies on the diagnostic and prognostic
biomarkers associated with IPF. The purpose of this study was to explore the diagnostic and …
biomarkers associated with IPF. The purpose of this study was to explore the diagnostic and …
[HTML][HTML] A novel therapeutic approach for IPF: Based on the “Autophagy-Apoptosis” balance regulation of Zukamu Granules in alveolar macrophages
S Li, G Liu, M Gu, Y Li, Y Li, Z Ji, K Li, Y Wang… - Journal of …, 2022 - Elsevier
Abstract Ethnopharmacological relevance Zukamu Granules (ZKMG) is one of the
representative Uygur patent drugs widely used in China, which is included in the National …
representative Uygur patent drugs widely used in China, which is included in the National …
Idiopathic pulmonary fibrosis
S Saha, S Majumdar, P Bhattacharyya - Pulmonomics: Omics Approaches …, 2023 - Springer
The unknown aetiology of irreversible fibrotic scarring of lung tissues in Idiopathic
Pulmonary Fibrosis (IPF) has resulted in the lack of a gold standard for disease diagnosis …
Pulmonary Fibrosis (IPF) has resulted in the lack of a gold standard for disease diagnosis …
[HTML][HTML] Immune mechanisms and novel therapies for idiopathic pulmonary fibrosis
D Gao, W Gao, Z Zhai, W Zhu - Pharmaceutical Science Advances, 2024 - Elsevier
Idiopathic pulmonary fibrosis (IPF), a progressive lung disease characterized by irreversible
lung dysfunction caused by fibroblast proliferation and excessive collagen deposition, is the …
lung dysfunction caused by fibroblast proliferation and excessive collagen deposition, is the …
Retracted: Identification and Validation of Potential Biomarkers and Pathways for Idiopathic Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis
BMR International - BioMed Research International, 2024 - ncbi.nlm.nih.gov
Retracted: Identification and Validation of Potential Biomarkers and Pathways for Idiopathic
Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis - PMC Back to Top Skip to …
Pulmonary Fibrosis by Comprehensive Bioinformatics Analysis - PMC Back to Top Skip to …
ОСОБЕННОСТИ ТЕЧЕНИЯ ФИБРОТИЧЕСКОГО ФЕНОТИПА ИНТЕРСТИЦИАЛЬНЫХ ЗАБОЛЕВАНИЙ ЛЕГКИХ У БОЛЬНЫХ, АССОЦИИРОВАННЫХ С …
АВ МЕДВЕДЕВ, АФ АБУБИКИРОВ, ЛА МАЗАЕВА - НАУКОСФЕРА … - elibrary.ru
Изучены результаты инструментального и лабораторного исследования больных
фибротическим фенотипом интерстициальных заболеваний легких (фИЗЛ) …
фибротическим фенотипом интерстициальных заболеваний легких (фИЗЛ) …